OBJECTIVE: Generalized anxiety disorder (GAD) is a prevalent and debilitating psychiatric condition of adolescence. Two effective forms of treatment are cognitive behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs). This pilot study examined changes in brain function following each type of treatment in GAD. METHOD: Subjects were 14 youths with GAD (7 had CBT, 7 received fluoxetine) and 10 age- and gender-matched healthy peers. Functional magnetic resonance imaging (fMRI) scans were acquired before and after treatment for patients and over two comparable time points for controls. During fMRI acquisition, a probe detection task with emotional (angry, happy) and neutral faces allowed for assessment of neural response to threat. Following previous research, region of interest analyses were performed in the right ventrolateral prefrontal cortex (VLPFC). RESULTS: fMRI results showed increased right VLPFC activation, relative to controls, in the medication (t(15) = 3.01, p < 0.01) and CBT (t(15) = 3.22, p < 0.01) groups following treatment. CONCLUSIONS: This study shows significant increase in right VLPFC activation in response to angry faces following treatment with CBT or fluoxetine for GAD. This is consistent with previous research indicating that the VLPFC may facilitate effective responding to underlying neural correlates of anxiety in other brain regions, such as the amygdala.
OBJECTIVE: Generalized anxiety disorder (GAD) is a prevalent and debilitating psychiatric condition of adolescence. Two effective forms of treatment are cognitive behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs). This pilot study examined changes in brain function following each type of treatment in GAD. METHOD: Subjects were 14 youths with GAD (7 had CBT, 7 received fluoxetine) and 10 age- and gender-matched healthy peers. Functional magnetic resonance imaging (fMRI) scans were acquired before and after treatment for patients and over two comparable time points for controls. During fMRI acquisition, a probe detection task with emotional (angry, happy) and neutral faces allowed for assessment of neural response to threat. Following previous research, region of interest analyses were performed in the right ventrolateral prefrontal cortex (VLPFC). RESULTS: fMRI results showed increased right VLPFC activation, relative to controls, in the medication (t(15) = 3.01, p < 0.01) and CBT (t(15) = 3.22, p < 0.01) groups following treatment. CONCLUSIONS: This study shows significant increase in right VLPFC activation in response to angry faces following treatment with CBT or fluoxetine for GAD. This is consistent with previous research indicating that the VLPFC may facilitate effective responding to underlying neural correlates of anxiety in other brain regions, such as the amygdala.
Authors: K Luan Phan; Daniel A Fitzgerald; Pradeep J Nathan; Gregory J Moore; Thomas W Uhde; Manuel E Tancer Journal: Biol Psychiatry Date: 2005-02-01 Impact factor: 13.382
Authors: Duncan B Clark; Boris Birmaher; David Axelson; Kelly Monk; Catherine Kalas; Mary Ehmann; Jeffrey Bridge; D Scott Wood; Bengt Muthen; David Brent Journal: J Am Acad Child Adolesc Psychiatry Date: 2005-12 Impact factor: 8.829
Authors: Ashley R Smith; Eric E Nelson; Brent I Rappaport; Daniel S Pine; Ellen Leibenluft; Johanna M Jarcho Journal: J Child Adolesc Psychopharmacol Date: 2018-05-24 Impact factor: 2.576
Authors: Krystal M Lewis; Chika Matsumoto; Elise Cardinale; Emily L Jones; Andrea L Gold; Argyris Stringaris; Ellen Leibenluft; Daniel S Pine; Melissa A Brotman Journal: J Child Adolesc Psychopharmacol Date: 2020-03-11 Impact factor: 2.576
Authors: Anna M Wehry; Katja Beesdo-Baum; Meghann M Hennelly; Sucheta D Connolly; Jeffrey R Strawn Journal: Curr Psychiatry Rep Date: 2015-07 Impact factor: 5.285
Authors: Daniel P Dickstein; Matthew F Pescosolido; Brooke L Reidy; Thania Galvan; Kerri L Kim; Karen E Seymour; Angela R Laird; Adriana Di Martino; Rowland P Barrett Journal: J Am Acad Child Adolesc Psychiatry Date: 2013-03 Impact factor: 8.829
Authors: Jillian E Hardee; Brenda E Benson; Yair Bar-Haim; Karin Mogg; Brendan P Bradley; Gang Chen; Jennifer C Britton; Monique Ernst; Nathan A Fox; Daniel S Pine; Koraly Pérez-Edgar Journal: Biol Psychiatry Date: 2013-03-13 Impact factor: 13.382